Sastasundar Ventures Limited has informed the Exchange regarding Proceedings of AGM held on September 26, 2025. Further, the company has submitted the Exchange a copy of Srutinizers report.
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sastasundar Ventures Limited held its 36th AGM on September 26, 2025 via video conferencing, chaired by Mr. B. L. Mittal, with 73 members attending. All three resolutions were passed with overwhelming majority (over 99.99% votes in favor). These included adoption of the audited financial statements (standalone and consolidated) for FY ended March 31, 2025, re-appointment of Mr. Ravi Kant Sharma (DIN: 00364066) as director retiring by rotation, and appointment of M/s MKB & Associates as Secretarial Auditor for a five-year term from FY 2025-26 to FY 2029-30. A total of 97 members cast their votes through remote e-voting. The Chairman highlighted the relaunch of the SastaSundar App, transition of the RetailerShakti B2B and SastaSundar B2C businesses, and digital initiatives including JitoHealth.com with AI-driven recommendations and a health podcast. The company is also working on simplifying its corporate structure.
This is a routine procedural filing with all agenda items passing easily, indicating no shareholder dissent on financials, director re-appointment, or auditor selection. While the digital business updates offer positive strategic visibility, the filing itself is unlikely to move the stock price materially.